Price to Sales (P/S)
since 2005
Calculation
Allergan PLC, P/S, long-term trends, calculation
| P/S | = | Share price1, 2, 3 | ÷ | Sales per share1 | Sales per share1 | = | Net revenues1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | 4.05 | = | 198.00 | ÷ | 48.90 | 48.90 | = | 16,088,900 | ÷ | 329,002,015 | |
| Feb 15, 2019 | 2.93 | = | 139.07 | ÷ | 47.46 | 47.46 | = | 15,787,400 | ÷ | 332,614,474 | |
| Feb 16, 2018 | 3.40 | = | 164.04 | ÷ | 48.26 | 48.26 | = | 15,940,700 | ÷ | 330,320,420 | |
| Feb 24, 2017 | 5.65 | = | 245.37 | ÷ | 43.47 | 43.47 | = | 14,570,600 | ÷ | 335,224,713 | |
| Feb 26, 2016 | 7.81 | = | 298.07 | ÷ | 38.18 | 38.18 | = | 15,071,000 | ÷ | 394,687,384 | |
| Feb 18, 2015 | 5.79 | = | 284.00 | ÷ | 49.06 | 49.06 | = | 13,062,300 | ÷ | 266,252,295 | |
| Feb 25, 2014 | 4.52 | = | 225.00 | ÷ | 49.81 | 49.81 | = | 8,677,600 | ÷ | 174,199,744 | |
| Feb 28, 2013 | 1.84 | = | 85.16 | ÷ | 46.27 | 46.27 | = | 5,914,900 | ÷ | 127,832,241 | |
| Feb 16, 2012 | 1.67 | = | 60.31 | ÷ | 36.05 | 36.05 | = | 4,584,400 | ÷ | 127,165,346 | |
| Feb 22, 2011 | 1.94 | = | 54.90 | ÷ | 28.35 | 28.35 | = | 3,566,900 | ÷ | 125,827,379 | |
| Mar 1, 2010 | 1.77 | = | 40.12 | ÷ | 22.61 | 22.61 | = | 2,793,000 | ÷ | 123,516,219 | |
| Feb 23, 2009 | 1.20 | = | 29.10 | ÷ | 24.23 | 24.23 | = | 2,535,501 | ÷ | 104,627,327 | |
| Feb 25, 2008 | 1.17 | = | 28.19 | ÷ | 24.09 | 24.09 | = | 2,496,651 | ÷ | 103,657,619 | |
| Mar 1, 2007 | 1.33 | = | 25.71 | ÷ | 19.31 | 19.31 | = | 1,979,244 | ÷ | 102,500,489 | |
| Mar 10, 2006 | 1.99 | = | 29.55 | ÷ | 14.83 | 14.83 | = | 1,646,203 | ÷ | 111,029,721 |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Allergan PLC Annual Report.
Comparison to Competitors
Allergan PLC, P/S, long-term trends, comparison to competitors
| Allergan PLC | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Moderna Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2020 | 4.05 | 4.22 | 6.03 | 5.52 | 6.29 | 6.03 | 4.00 | 4.79 | 4.33 | — | 3.66 | 5.34 | 4.83 |
| Feb 15, 2019 | 2.93 | 3.58 | 5.22 | 3.67 | 3.97 | 5.15 | 3.84 | 4.45 | 4.92 | — | 4.49 | 6.62 | 4.24 |
| Feb 16, 2018 | 3.40 | 6.67 | 5.82 | 5.02 | 3.70 | 3.71 | 4.10 | 4.56 | 3.68 | — | 4.05 | 5.92 | 4.01 |
| Feb 24, 2017 | 5.65 | 3.84 | 5.65 | 4.72 | 3.48 | 4.18 | 3.08 | 4.62 | 4.54 | — | 3.84 | 7.86 | 3.37 |
| Feb 26, 2016 | 7.81 | 3.83 | 5.28 | 6.07 | 2.91 | 4.02 | 3.80 | 4.13 | 3.56 | — | 3.76 | 9.38 | 3.05 |
| Feb 18, 2015 | 5.79 | 4.90 | 6.13 | 6.28 | 3.09 | 4.03 | 6.36 | 3.77 | 3.93 | — | 4.24 | 14.62 | 3.06 |
| Feb 25, 2014 | 4.52 | 4.31 | 5.22 | 5.48 | 2.78 | 2.81 | 11.95 | 3.63 | 3.78 | — | 3.97 | 15.52 | 3.74 |
| Feb 28, 2013 | 1.84 | 3.30 | 4.09 | 3.40 | 2.32 | 2.71 | 6.95 | 3.17 | 2.73 | — | 3.34 | 11.66 | 2.12 |
| Feb 16, 2012 | 1.67 | — | 3.52 | 2.63 | 2.28 | 1.87 | 4.22 | 2.75 | 2.43 | — | 2.37 | 20.90 | 1.77 |
| Feb 22, 2011 | 1.94 | — | 3.32 | 2.23 | 2.48 | 1.73 | 4.19 | 2.65 | 2.18 | — | 2.27 | 7.38 | 2.00 |
| Mar 1, 2010 | 1.77 | — | 3.88 | 2.27 | 2.16 | 1.82 | 6.64 | 2.82 | 4.23 | — | 2.83 | 5.74 | 1.98 |
| Feb 23, 2009 | 1.20 | — | 3.44 | 1.96 | 1.30 | 1.66 | 8.03 | 2.37 | 2.14 | — | 1.72 | 5.17 | 1.44 |
| Feb 25, 2008 | 1.17 | — | 3.46 | 2.30 | 2.16 | 3.05 | 10.90 | 2.95 | 4.04 | — | 3.11 | 11.94 | 2.40 |
| Mar 1, 2007 | 1.33 | — | 5.41 | 3.07 | 2.30 | 3.80 | 12.67 | 3.53 | 4.23 | — | 3.67 | 19.70 | 5.05 |
| Mar 10, 2006 | 1.99 | — | 7.24 | 2.34 | 2.40 | 4.31 | 15.36 | 3.49 | 3.50 | — | 3.77 | 14.06 | 2.15 |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Allergan PLC, P/S, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Allergan PLC | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 18, 2020 | 4.05 | 4.79 |
| Feb 15, 2019 | 2.93 | 4.46 |
| Feb 16, 2018 | 3.40 | 4.51 |
| Feb 24, 2017 | 5.65 | 4.24 |
| Feb 26, 2016 | 7.81 | 4.05 |
| Feb 18, 2015 | 5.79 | 4.46 |
| Feb 25, 2014 | 4.52 | 4.25 |
| Feb 28, 2013 | 1.84 | 3.24 |
| Feb 16, 2012 | 1.67 | 2.56 |
| Feb 22, 2011 | 1.94 | 2.41 |
| Mar 1, 2010 | 1.77 | 2.96 |
| Feb 23, 2009 | 1.20 | 2.20 |
| Feb 25, 2008 | 1.17 | 3.18 |
| Mar 1, 2007 | 1.33 | 3.87 |
| Mar 10, 2006 | 1.99 | 3.82 |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Allergan PLC, P/S, long-term trends, comparison to industry (health care)
| Allergan PLC | Health Care | |
|---|---|---|
| Feb 18, 2020 | 4.05 | 2.13 |
| Feb 15, 2019 | 2.93 | 2.33 |
| Feb 16, 2018 | 3.40 | 2.30 |
| Feb 24, 2017 | 5.65 | 2.12 |
| Feb 26, 2016 | 7.81 | 2.10 |
| Feb 18, 2015 | 5.79 | 2.38 |
| Feb 25, 2014 | 4.52 | 2.17 |
| Feb 28, 2013 | 1.84 | 1.73 |
| Feb 16, 2012 | 1.67 | 1.55 |
| Feb 22, 2011 | 1.94 | 1.46 |
| Mar 1, 2010 | 1.77 | 1.64 |
| Feb 23, 2009 | 1.20 | 1.36 |
| Feb 25, 2008 | 1.17 | 2.01 |
| Mar 1, 2007 | 1.33 | 2.43 |
| Mar 10, 2006 | 1.99 | 2.72 |
Based on: 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).